Please login to the form below

Not currently logged in
Email:
Password:

Mundipharma appoints chief information officer

Philippe Mazas joins the UK-based pharma network from Smith & Nephew

Philippe MazasMundipharma, a global network of privately-owned independent associated pharma companies, has appointed a new chief information officer in the form of Philippe Mazas.

He joins the network with almost 20 years’ experience as a chief information officer and most recently served Smith & Nephew.

His new role will see him take responsibility for the IT services provided to Mundipharma’s global network of associated companies.

Mazas said: “Taking an entrepreneurial approach to technology is vital for pharma companies that want to stay ahead of the every advancing pace of digital transformation.

“My goal is to ensure that the Mundipharma network has the technology support it needs to lead the charge in pharma by being customer focused, value driven and business led.

“This approach will enable us to be more efficient and nimble, while ensuring the Mundipharma network continues to advance technology to aid in the development and commercialisation of medicines that address patients’ needs.”

5th January 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics